Heron Therapeutics ( (HRTX) ) has provided an announcement.
An update from MaxCyte ( (MXCT)) is now available. On March 16, 2026, MaxCyte received notice from Nasdaq that its common stock had closed below $1.00 per share for 30 consecutive trading days, ...
SINGAPORE, June 06, 2025 (GLOBE NEWSWIRE) -- JBDI Holdings Limited (“JBDI” or the “Company”) (Nasdaq: JBDI), today announced that it has received notice (the “Notice”) from the Nasdaq Stock Market ...
The performance of this secondary market element of the stock market is tracked through various stock market indices, like ...